Zions Bancorporation, N.A. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 288 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
Zions Bancorporation, N.A. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$7,255
-16.3%
469
-15.0%
0.00%0.0%
Q2 2023$8,672
-24.4%
552
-20.7%
0.00%0.0%
Q1 2023$11,470
+6.9%
696
+1.2%
0.00%0.0%
Q4 2022$10,733
+257.8%
688
+214.2%
0.00%
Q3 2022$3,000
-25.0%
219
-17.7%
0.00%
Q2 2022$4,000
-55.6%
266
-58.4%
0.00%
-100.0%
Q1 2022$9,000
+125.0%
640
+149.0%
0.00%
Q4 2021$4,000
-55.6%
257
-54.4%
0.00%
-100.0%
Q3 2021$9,000
-35.7%
564
-33.7%
0.00%0.0%
Q2 2021$14,000
-41.7%
851
-34.3%
0.00%
-66.7%
Q1 2021$24,0000.0%1,296
-3.2%
0.00%0.0%
Q4 2020$24,000
-41.5%
1,339
-41.9%
0.00%
-50.0%
Q3 2020$41,000
+485.7%
2,303
+484.5%
0.01%
+500.0%
Q2 2020$7,000
-61.1%
394
-67.2%
0.00%
-66.7%
Q1 2020$18,000
-10.0%
1,200
+18.2%
0.00%0.0%
Q4 2019$20,000
+17.6%
1,015
+4.9%
0.00%
+50.0%
Q3 2019$17,000
+21.4%
968
+23.6%
0.00%0.0%
Q2 2019$14,000
-75.4%
783
-71.9%
0.00%
-77.8%
Q1 2019$57,0002,7840.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2021
NameSharesValueWeighting ↓
Glenview Capital Management 16,104,222$294,063,0004.98%
GMT CAPITAL CORP 2,468,695$45,078,0003.31%
MANAGED ASSET PORTFOLIOS, LLC 1,065,756$19,461,0003.13%
Blackcrane Capital, LLC 14,571$1,723,0002.72%
BFAM Partners (Cayman) Ltd 328,690$6,002,0002.36%
Paulson & Co. 4,727,415$86,323,0001.98%
Mondrian Investment Partners LTD 3,510,404$59,677,0001.28%
Lumbard & Kellner, LLC 135,550$2,264,0000.80%
DAVIDSON INVESTMENT ADVISORS 500,203$9,134,0000.78%
TFG Asset Management GP Ltd 589,390$10,762,0000.77%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders